Please assess the completion status of the following clinical trial:

Trial Title: Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Ages: 21 to 80~2. Microscopically confirmed premalignant oral epithelial disease~3. No previous history of cancer (with the exception of basal cell carcinoma of the skin)~4. Tobacco free for at least six weeks prior to entrance in the trial and remain tobacco-free for the three month duration of the study~5. Availability for necessary study follow-up evaluations (every 10 to 14 days during the trial)~6. Capable of providing informed consent.~Exclusion Criteria:~1. Previous history of cancer (with the exception of basal cell carcinoma of the skin)~2. Current use of tobacco products or refusal to remain tobacco-free for the three month duration of the study~3. Lack of microscopically confirmed premalignant oral epithelial changes~4. Microscopic diagnosis of oral squamous cell carcinoma~5. Previous history of radiation therapy on same side of the head and neck region~6. History of allergy to any kind of berry~7. Women who are determined to be pregnant or plan to be pregnant during the trial~8. Women who are nursing.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 10% FBR containing bioadhesive gel (Type: ACTIVE_COMPARATOR): Drug consisting of 10% FBR containing bioadhesive gel. Participants instructed to apply 0.5 gm of 10% FBR containing bioadhesive gel four times a day to lesional site
- Placebo Gel (Type: PLACEBO_COMPARATOR): Color/consistency matched placebo (no black raspberry) gel

Based on this trial design, predict the completion outcome and termination type (if applicable).